“An Explosion in Therapeutics”: the RECOVER Long COVID Biomarker Talk and Its Implications for Chronic Fatigue Syndrome and Fibromyalgia
Suzanne Vernon Ph.D. on the RECOVER Initiative and ME/CFS, Peroxisomes, the Gut, Viral Persistence and Upcoming Treatment Trials
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
Multi-omics Study Links Poor Sleep to Deficient Gut Bacteria in ME/CFS
The “omics” studies (genomics, metabolomics, proteomics, transcriptomics) are all the rage. These studies are attempting to get at the molecular roots of chronic fatigue syndrome (ME/CFS), but there’s a problem. ME/CFS is probably not just a...
Enhancing Butyrate and Gut Health in ME/CFS, Fibromyalgia, Long COVID and Allied Disorders
Several studies suggest that butyrate-producing bacteria are reduced in people with chronic fatigue syndrome (ME/CFS) and possibly fibromyalgia (FM) and long COVID. The fact that three different techniques have found reduced levels of butyrate-reducing bacteria in...
Does Mast Cell Activation Explain IBS (and Fibromyalgia and ME/CFS)?
Irritable bowel syndrome (IBS) is a pretty big deal. The most common gut disorder, IBS, costs the U.S. economy about $1 billion a year and occurs in a considerable number of people with chronic fatigue syndrome (ME/CFS) and/or fibromyalgia (FM). It, ME/CFS and FM,...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
